0001104659-20-065429.txt : 20200522
0001104659-20-065429.hdr.sgml : 20200522
20200522170039
ACCESSION NUMBER: 0001104659-20-065429
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200521
FILED AS OF DATE: 20200522
DATE AS OF CHANGE: 20200522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAY WILLIAM GARRETT
CENTRAL INDEX KEY: 0001692961
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38128
FILM NUMBER: 20906771
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET,
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc.
CENTRAL INDEX KEY: 0001651407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472568632
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 212-554-4366
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
tm2020700-1_4.xml
FORM 4
X0306
4
2020-05-21
0
0001651407
Checkpoint Therapeutics, Inc.
CKPT
0001692961
GRAY WILLIAM GARRETT
2 GANSEVOORT STREET,
9TH FLOOR
NEW YORK
NY
10014
0
1
0
0
See Remarks
COMMON STOCK
2020-05-21
4
S
0
17104
1.995
D
359896
D
In connection with the vesting of 50,000 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Gray's tax withholding obligations. Mr. Gray had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.98 to $2.031. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Includes shares of restricted Common Stock, which vest over various time periods
Principal Financial Officer, VP Finance and Accounting
/s/ Garrett Gray
2020-05-22